Glucient Sr

Glucient Sr is a prescription medication that contains the active ingredient Metformin Hydrochloride. The product is marketed in the European Union and is administered orally. While the specific strength and dosage form are not disclosed, Glucient Sr belongs to the biguanide class of antidiabetic drugs and is used to help manage blood glucose levels in adults with type 2 diabetes mellitus.

Glucient Sr is indicated for the management of type 2 diabetes mellitus as part of a comprehensive treatment plan that includes diet and exercise.

- Improves glycemic control in adults with type 2 diabetes. - Used as monotherapy when diet and exercise alone are insufficient. - Can be combined with other antidiabetic agents for enhanced effect. - May be prescribed when other oral hypoglycemics are not tolerated. - Supports long‑term reduction of hyperglycemia-related complications.

Metformin, the active component of Glucient Sr, may cause a range of side effects. Most are mild and transient, but some require medical attention.

Common: - Gastrointestinal upset such as nausea, abdominal discomfort, or diarrhea. - Metallic taste in the mouth. - Decreased appetite. - Mild headache. - Unexplained weight loss.

Serious: - Lactic acidosis, a rare but life‑threatening condition. - Severe skin reactions like Stevens‑Johnson syndrome. - Persistent vomiting leading to dehydration. - Significant elevation of liver enzymes. - Hypoglycemia when combined with other glucose‑lowering drugs.

Before starting Glucient Sr, certain health considerations should be reviewed to ensure safe use.

- Assess renal function; avoid use in severe renal impairment. - Monitor liver enzymes periodically. - Use caution in patients with a history of heart failure or unstable cardiovascular disease. - Evaluate for alcohol consumption, which may increase risk of lactic acidosis. - Discontinue before any radiographic studies involving iodinated contrast agents. - Pregnant or breastfeeding women should consult a healthcare professional before use.

Glucient Sr can interact with several medications, affecting its efficacy or safety profile.

Avoid: - Iodinated contrast media used in imaging studies. - Cimetidine, which may increase metformin plasma concentrations. - Certain antiretroviral drugs (e.g., didanosine) that raise the risk of lactic acidosis.

Use with caution: - Diuretics that may affect renal function. - Beta‑blockers, which can mask hypoglycemia symptoms. - Other antidiabetic agents, especially sulfonylureas, due to additive glucose‑lowering effects. - ACE inhibitors or ARBs, requiring monitoring of renal function.